Universal (UVV) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 FY2025 rose 15% year-over-year to $597.1 million, with both Tobacco and Ingredients segments contributing to growth.

• Operating income increased 56% to $17.2 million, driven by higher sales volumes and prices.

• Net income was $0.1 million ($0.01 per diluted share), reversing a net loss of $2.1 million in the prior year quarter.

• Strong demand for tobacco and new product sales in Ingredients supported results; Lancaster, PA expansion on track for H2 FY2025.

• Debt levels remain elevated due to working capital needs, but 87% of tobacco inventory is committed, and working capital is expected to unwind during FY2025.

Financial highlights

• Sales and other operating revenue: $597.1 million, up $79.3 million (15%) year-over-year.

• Operating income rose by $6.2 million to $17.2 million year-over-year.

• Gross profit margin was 16.1%, down 60 bps from 16.7% in the prior year quarter due to higher cost of goods sold.

• Net income for the quarter was $0.1 million, or $0.01 per diluted share, up $2.2 million year-over-year.

• Selling, general, and administrative expenses rose by $3.2 million, mainly due to unfavorable foreign currency comparisons.

Outlook and guidance

• Tobacco shipment timing and revenue recognition expected to be more weighted toward the second half of fiscal 2025.

• Elevated green tobacco prices are expected to incentivize increased planting, potentially balancing the market in coming years.

• Lancaster, PA facility expansion expected to contribute meaningfully to Ingredients segment in FY2026.

• SG&A expenses projected to come in below last year’s $311 million for fiscal 2025.

• Working capital and debt levels are expected to decline as committed inventories are processed and delivered.